Tag Archives: ideas

Revisiting A Paradigm Shift: Allocation Decisions In The Absence Of Theory

Problems with CAPM and EMH suggest that Modern Portfolio Theory is not useful for individual investors. As a result, modern finance is in the midst of a paradigm shift similar to those discussed by Kuhn (1962). On an interim basis, using James Montier’s trinity of risk plus behavioral finance as an overlay may work. James Montier, the famous value investor now at GMO Asset Management, has written extensively about the huge contradictions between academic theory and real world observations when it comes to the dynamic between risk and reward in the markets. This is a topic I have been interested in for a long time, because the disjunction between theory and practice should (but usually doesn’t) strongly affect how investment managers view risk and construct client portfolios. Montier began his argument with a review of the evolution of market theory, and especially that part of theory called the Capital Asset Pricing Model, or CAPM. In the 1950’s future Nobel Laureate Harry Markowitz wrote his Ph.D. thesis on a mathematical model for asset allocation called portfolio optimization. His model could theoretically be used to construct portfolios that combined maximum gain with minimum risk for any investor whose assets were diversified. Eventually this approach led, in conjunction with the CAPM, to what is now called Modern Portfolio Theory (MPT). Many institutions today use a modified version of MPT to develop their recommended asset allocations. The CAPM part of modern theory was introduced by Nobel Laureate William Sharpe and his colleagues in the 1960’s. In brief, the CAPM assumed that all investors would use Markowitz’s optimization method, so that a single mathematical factor could be isolated that would distinguish between stocks of differing risk levels, and that factor is called beta (i.e., beta is that part of a stock’s risk that can be attributed to market fluctuations that are systematic and undiversifiable, and this in turn depends in part on a stock’s correlation to the market, as represented by the S & P 500). The final component of MPT was the development of a concept called the Efficient Market Hypothesis by Nobel Laureate Eugene Fama. As part of his work Fama attempted to prove that information is equally available to all players in the markets, so therefore the markets are efficient and all stocks are correctly priced. Over time this idea led directly to the notion that the best investment approach is to use passive indexes to fill out a portfolio allocation, since no one should expect to beat efficient markets for any substantial period of time. It is important to note that this idea of efficient markets is really just an assumption used to make mathematical treatment possible. There is abundant evidence that the assumption of market efficiency is false, as has been discussed by Warren Buffett, John Mauldin and many others. One only needs to think back to the NASDAQ bubble in the late 1990’s and its subsequent collapse, or the carnage of the Great Financial Crisis in 2008, to find glaring examples of inefficient markets. A basic tenet of CAPM is that risk and reward are directly proportional. This means that as risk increases, so does reward. However, a study in the late 2000s by JPMorgan has shown just the opposite trend for real world data. In other words, when 20 years of actual market (the Russell indexes) data through 2008 were plotted, they indicated a strong linear relationship between risk and reward all right, but it was reciprocal. Thus, if risk increases in the real markets, reward can actually decrease. Indeed, Fama and his long-time colleague French published a paper in 2004 showing that for the period from 1923 to 2003, using all stocks on the NYSE, AMEX and NASDAQ, the highest risk (highest beta) stocks considerably underperformed relative to the predictions of the CAPM. The reverse was also true, in that the lowest risk (lowest beta) stocks considerably outperformed relative to the predictions of the CAPM. Over the long run, there was essentially no relationship between beta and stock returns. Yet another study was conducted a few years ago by Jeremy Grantham of GMO Asset Management, who found that for the 600 largest U.S. stocks (for the time period from 1963 to 2006), those with the lowest beta have had the highest returns. Montier himself has studied the risk-return relationship for European stocks for the period from 1986 to 2006 as well, with essentially the same result. Montier’s explanation for the failure of the CAPM over shorter time frames is based on the many questionable assumptions that have to be made for the model to “work” mathematically. Amongst the more questionable assumptions are: 1) no taxes are paid, so investors are indifferent between dividends and capital gains; 2) all investors use Markowitz portfolio optimization at all times; and 3) investors can take any position (long or short) without affecting the market price. These assumptions are implicitly accepted by all who use MPT and CAPM to manage portfolios, such as many institutional asset managers. These may indeed be valid over very long time frames, but then they may not be appropriate for mere mortals to use with their personal investments. This assumed validity reaches its ultimate level of absurdity in the obsession many financial institutions have for so-called short term “tracking error”. Tracking error measures the variability in the difference between a fund manager’s portfolio returns and the returns of the appropriate stock index. Many institutional managers have been compensated on the basis of tracking error. Thus, the variance in investor portfolio returns has not always been considered; rather, a manager’s relative performance against an index is the criterion by which they are commonly judged. This means that if the market loses 20% in a given year and the manager only loses 18%, that manager may very well bonus for outperformance on a tracking error basis, even though their clients lost significant money. Modern hedge funds are in part the profession’s response to client angst over this state of affairs. Many hedge funds attempt to provide steady absolute returns, and that is why they have become so popular amongst high net worth clients. Unfortunately, retail clients until recently had no sophisticated risk-control strategies available to them, but that is changing. If you accept for the purposes of argument that both CAPM and the Efficient Markets Hypothesis are invalid or at least suspect, then you are presented with a dilemma. MPT doesn’t really work except during 50 year periods and longer, which is way too long for use with retail clients, but it is the only theory with any mathematical rigor that is widely accepted. This situation is reminiscent of the problems faced in the physical sciences when an old foundational theory or paradigm has been tossed out, but a new one has not yet appeared. The classic examples are the paradigm shift that occurred when Newton proposed his gravitational theory, and again when Einstein proposed his theories about relativity. This problem was written about brilliantly by Thomas S. Kuhn in his book on “The Structure of Scientific Revolutions,” published in 1962. What generally happens is that the old guard defends the old paradigm even while it is being destroyed as an explanatory tool by new data, so that only younger scientists like Newton and Einstein can break through to new paradigms, and then only when the old guard stops fighting. A famous quote on the matter is attributed to the physicist Max Planck in the early 1900s: “Science progresses one funeral at a time.” I believe, as do others, that this is where we now find ourselves with respect to MPT. Grad schools still teach it, but applying it during the sequential bubbles of the last 20 years has yielded awful results on a risk-adjusted basis. Over an even longer period, since 1982, 30-year zero coupon bonds have beaten the S & P 500 by an absolutely huge margin, as Gary Shilling has been pointing out for many years. The careful practitioner then has a dilemma, assuming that he or she now rejects the old MPT paradigm: there is no mathematically rigorous new paradigm to replace it with. How do we go about asset allocation then? Many others have explored this question in recent years, but with a possible new bear market ahead of us sometime in 2016 or 2017, there is renewed urgency to the quest for answers. Behavioral finance has provided a rich and powerful explanation for what happens in the real world of the markets. It should be a major part of the equation, and goes a long way towards explaining the problems with MPT, but it is not inherently mathematical itself. I am reconciled to thinking that since human beings are involved in economics and markets, there will be no mathematical solution. I personally have been using Montier’s “trinity of risk” concept as a template for making allocation decisions. His trinity consists of valuation risk, business/earnings risk, and balance sheet/financial risk. These can be applied in some way to most asset classes. But a behavioral finance overlay can be useful as well. It is on this basis that I have written elsewhere that I strongly favor certain bonds over stocks, and possibly even over cash, in 2016. The most important conclusion for investors to draw from this discussion is that the assumptions that underlie an asset manager’s approach should be examined carefully and judged for their conformity with that investor’s investment goals. Most will reject the notion that periodic 50% losses are acceptable, so a more risk-aware approach is needed. I realize that I have not really answered all of the questions I have posed; clearly this is a work in progress.

3 High Momentum Stocks And ETFs For The Santa Rally

A consensus carried out from 1950 to 2013 has revealed that December has ended up offering positive returns in 49 years and negative returns in 16 years, with an average return of 1.59%, as per moneychimp.com , the best in a year. But U.S. stocks have defied the seasonal trend this time around. The first Fed rate hike in almost a decade and possibilities of four more hikes next year along with horribly low oil prices might make Christmas a little dull this year, curbing the natural progression of the end-of-season ascent, commonly known as the Santa Clause rally. What is Santa Rally? Santa Claus rally refers to the jump in stock prices in the week between Christmas and New Year’s Day. There are several reasons behind this surge including ‘tax considerations, happiness around Wall Street, people investing their Christmas bonuses and the fact that the pessimists are usually on vacation this week’ as per investopedia. In fact, some even believe that investors buy stocks during this period to cash in on another strong equity event, known as the January Effect, which takes place soon after. As per the 2016 Stock Trader’s Almanac, in the last 45 holiday seasons, the Santa Claus rally has delivered positive returns 34 times with the average cumulative return being 1.4%. If we go a little deeper, the consistency of this rally would be more visible. The Dow Jones Industrial Average has returned about 1.7% (on an average) since 1896. However, the Santa Claus rally failed to live up to investors’ expectation several times including in 1990, 1999, 2004, 2007, and 2014, per Business Insider . Will 2015 See a Santa Rally? With just three days to go for Christmas, there are hardly any indications of such a surge. Global stocks were at great health last week with the S&P 500 recording its ‘ best week since October 24, 2014’. But stocks lost their steam at the start of this week. All in all, the situation is shaky, but thanks to compelling valuation (after the latest sell-off), one can’t ignore the prospect of a Santa rally this year as well. Currently, the U.S. economy appears to be the lone star in a tottering global backdrop. This fact, along with compelling valuation brings about bright opportunities for some U.S.-based momentum stocks and ETFs in the coming days, especially in a market rebound. After all, no storm lasts forever. Thus, momentum investing might be an intriguing idea for those seeking higher returns in a short spell. Momentum investing looks to reflect profits from buying stocks, which are sizzling on the market. Below we highlight three momentum stocks and ETFs to watch out for in the coming trading sessions. Stock Picks For stocks, we have chosen top picks using the Zacks Screener that fits our three criteria: momentum score of ‘A’, stock Zacks Rank #1 (Strong Buy) and positive estimate revision for the current quarter. Here are the three recommended stocks. American Eagle Outfitters Inc. (NYSE: AEO ) Based in Pennsylvania, this retailer of apparel and accessories has delivered an average positive earnings surprise of 16.7% over the trailing four quarters. The consensus estimate for the current quarter has risen from 40 cents to 42 cents per share in the last 30 days as six analysts raised their forecast, while just one cut its estimate. Along with Momentum score of ‘A’, the stock also has a Growth and Value score of ‘A’. This Zacks Rank #1 stock is up 8.9% so far this year (as of December 21, 2015). B&G Foods Inc. (NYSE: BGS ) The company makes and markets packed and easy-to-store food and household products. Its products basket carries hot cereals, fruit spreads, canned meats and beans and many more. B&G has a Zacks Rank #1 and is up over 16.6% so far this year. The stock currently has a solid Zacks Industry Rank in the top 37%. The consensus estimate for the current quarter has risen from 42 cents to 44 cents per share . Caesars Entertainment Corporation (NASDAQ: CZR ) The Nevada-based company offers casino-entertainment and hospitality services in the U.S. and abroad. The stock currently has a Value score of ‘A’ and the solid Zacks Industry Rank in the top 15%. In the last 30 days, its projection of losses contracted from 27 cents to 14 cents. No analyst cut their estimate in the last 7, 30 and 60 days period, though there were positive revisions. Though this Zacks Rank #1 and high-momentum stock is down 50.9% so far this year, it added over 4.3% in the last one month. ETF Picks iShares MSCI USA Momentum Factor ETF (NYSEARCA: MTUM ) This ETF seeks to track the performance of large- and mid-cap U.S. stocks exhibiting relatively higher momentum characteristics. The fund has attracted about $1.1 billion is assets so far. With an expense ratio of just 15 basis points, this is one of the cheapest options in the high momentum ETFs space. The ETF is tilted toward the Consumer Discretionary and Information Technology sectors. Each of these takes over 25% of the basket. The next two spots are occupied by Consumer Staples and Health Care, each with double-digit weight. Amazon (NASDAQ: AMZN ) is currently the top holding of the fund, with Facebook (NASDAQ: FB ), Home Depot (NYSE: HD ), Visa (NYSE: V ) and Starbucks (NASDAQ: SBUX ) rounding out the top five. MTUM is up 7.2% so far this year but lost 1.3% in the last one month, though lesser than SPY (down over 3.5%). SPDR Russell 1000 Momentum Focus ETF (NYSEARCA: ONEO ) This new ETF has amassed about $325.8 million in assets in less than a month. The fund looks to track the performance of a segment of large-capitalization U.S. equity securities demonstrating a combination of core factors with a focus factor comprising high momentum characteristics. This 918-stock ETF is heavy on Consumer Discretionary (20.05%) followed by financial services (16.84%) and producer durables (16.37%). The fund charges 20 bps in fees and added about 3% in the last five trading sessions (as of December 21, 2015). First Trust Dorsey Wright Focus 5 ETF (NASDAQ: FV ) This ETF hovers around technical indicators such as relative strength. The fund is designed to identify the five First Trust sectors and industry-based ETFs that are arguably expected to have the maximum chance of outperforming the other ETFs in the selection universe. Securities with high relative strength scores (strong momentum) are given higher weights. Currently, the fund has the highest exposure to the ETF following Biotech, Internet and Health Care. The fund has already managed to attract more than $4.56 billion in assets. It is a slightly expensive choice thanks to its “enhanced indexing” approach, with an expense ratio of 94 basis points. The fund is up 5.7% so far this year. Original post

5 Market-Beating Broad International ETFs Of 2015

This has been a pretty rough year for the global stock market. Several China-driven offhand events causing global market rout in mid-year, growth worries in global superpowers like the Eurozone, Japan and Canada, Greek debt deal drama, the vicious cycle of oil price declines, commodity market upheaval, and finally the Fed rate hike in almost a decade kept the global markets edgy throughout the year. The impact of these events was harsh on the bourses. SPDR S&P 500 ETF (NYSEARCA: SPY ) has lost about 1% so far this year (as of December 22, 2015), Vanguard FTSE Europe ETF (NYSEARCA: VGK ) has shed about 5.1% during the same timeframe, iShares MSCI Emerging Markets (NYSEARCA: EEM ) has retreated as much as 16.9%, iShares MSCI All Country Asia ex Japan (NASDAQ: AAXJ ) has plummeted 11.5% and all-world ETF iShares MSCI ACWI (NASDAQ: ACWI ) has gone down over 4.7%. The price performance of these region-based ETFs was enough to tag 2015 as a down year for global stocks, on an average. In fact, as China devalued its currency yuan in a historic move in mid-August, there was a bloodbath in global equities. The U.S. and Asian stocks experienced a three -year low monthly performance in August. Europe saw the most horrible month since the 2011 debt debacle. Commodities crumbled to multi-year lows on demand issues and hit hard all commodity-rich nations. Still, the global market recouped some of its losses as the ECB extended its QE policy, BoJ made pro-growth changes in its accommodative policies and the Fed enacted a lift-off citing steady U.S. economic growth in the latter part of the year. These may give enough reasons to investors to look for international ETF survivors this year. For them, we have highlighted five ETFs that have gained at least 6% so far this year (as of December 22, 2015) defying the broad-based gloom. WisdomTree Intl Hedged Quality Div Growth ETF (NYSEARCA: IHDG ) While the Fed had been preparing for policy tightening the entire year and finally hiked rates, other developed economies of the world and a few emerging economies are going the opposite direction. Due to growth issues, global superpowers like Europe, Japan and Australia are presently pursuing easy money policies. As a result, stocks of these developed nations got an extra boost. Also, a currency-hedged approach was essential to set off the effect of a surging greenback. IHDG serves both aspects. Moreover, IHDG takes care of investors’ income too as the fund selects dividend-paying companies with growth features in the developed world ex U.S. and Canada. This Zacks ETF Rank #3 (Hold) ETF was up over 10% so far in 2015. SPDR SP International Consumer Staples Sector ETF (NYSEARCA: IPS ) This international consumer staples ETF has double-digit exposure in U.K., Japan and Switzerland. Other nations like France, Netherlands, Belgium also get weight in the range of 6-8%. Nestle ( OTCPK:NSRGY ) (13.58%) takes the top spot in the fund followed by Anheuser-Busch InBev (NYSE: BUD ) (5.9%) and British American Tobacco (NYSEMKT: BTI ) (5.85%). Ongoing easy policy measures and non-cyclical nature of the consumer staples sector helped the fund to endure global market shocks. IPS is up 8.8% so far this year (as of December 22, 2015). iShares MSCI EAFE Small-Cap ETF (NYSEARCA: SCZ ) This ETF targets the small cap segment of the developed market space. Small caps are considered the measure of domestic economy. These are less ruffled by global economic concerns and most importantly the surging U.S. dollar. Since cheap money available in Japan, Germany and U.K. resulted in improving consumer sentiment in those regions, this small-cap ETF emerged as a winner. SCZ is up over 7.7%. SPDR S&P International Health Care Sector ETF (NYSEARCA: IRY ) Health care is another recession-proof sector and thus remained less ruffled in the down year of 2015. The fund puts double-digit weight in Switzerland (25.44%), Japan (17.15%) and U.K. (14.30%) and Germany (10.23%). The fund is heavy on pharmaceuticals sector (74.27%) followed by Health Care Equipment & Supplies (9.45%). IRY has advanced over 7% so far this year (as of December 22, 2015). iShares MSCI EAFE Minimum Volatility (NYSEARCA: EFAV ) This fund targets the low volatility stocks of the developed equity markets, excluding the U.S. and Canada. In terms of country profile, Japan and United Kingdom take the top two spots at 28.5% and 24.2%, respectively, followed by Switzerland (10.43%). It is slightly tilted toward financials at 21.7%, closely followed by consumer staples (16.8%), health care (15.9%), industrials (11.1%) and consumer discretionary (10.6%). The fund is up 6.5% so far this year (as of December 22, 2015). The fund has a Zacks ETF Rank #3 (Hold) with a low risk outlook. Original Post